This peptide corresponds to residues 411-420 of the spike protein of SARS-CoV and identified as a positive control for HLA binding studies.
Peptide Library Construction and Screening
Powerful screening tools in biological and chemical research
Sequence | One Letter Code: KLPDDFMGCV Three-Letter Code: H-Lys-Leu-Pro-Asp-Asp-Phe-Met-Gly-Cys-Val-OH |
Purity | % Peak Area By HPLC ≥ 95% |
Size | 1 mg NET peptide |
References | 1. Lv Y, et al. Identification of a novel conserved HLA-A* 0201-restricted epitope from the spike protein of SARS-CoV. BMC immunology. 2009 Dec 1;10(1):61.2. Zhou M et al. Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. The Journal of Immunology. 2006 Aug 15;177(4):2138-45. |
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com